AK

Arun Kumar Pillai

Active Director Director DIN 00084845 India's Richest · #551
DIN 00084845 First appointment Mar 1994 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 28 historical roles
Total affiliations 37 Since Mar 1994
Shareholding value •••• Premium profile

About Arun Kumar Pillai

Data last updated:

Arun Kumar Pillai is a Director at Strides Pharma Science Limited (since 2025), Director at Onesource Specialty Pharma Limited (since 2021) and Director at Solara Active Pharma Sciences Limited (since 2021), and holds 6 more current directorships. The companies operate in Pharma, Chemicals and Business Outsourcing. The 6 current companies with reported revenue have a combined latest revenue of ₹7,778 Cr; the largest is Strides Pharma Science Limited at ₹5,009 Cr (FY 2026). Earlier, Arun Kumar Pillai was a Designated Partner at Qualichem Remedies Llp (2010–2025) and Additional Director at Quadgen Wireless Solutions Private Limited (2023–2024) and 26 more.

Arun Kumar Pillai is #551 among India's richest people (2026), with wealth of ₹6,100 Cr.

DIN 00084845
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 1994
Oldest Company Age 36 yrs
Largest company Strides Pharma Science Limited · ₹5,009 Cr (FY 2026)
Combined revenue ₹7,778 Cr across 6 companies

Recognitions & Rankings

India's Richest People 2026 edition · Source: Hurun India
Rank#551
Wealth
₹6,100 Cr
Company
Viyash Scientific

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Strides Pharma Science Limited L24230MH1990PLC057062
Director05 Apr 20251990₹5,009 Cr (FY 2026)Active
Onesource Specialty Pharma Limited L74140MH2007PLC432497
Director07 Apr 20212007₹1,437 Cr (FY 2026)Active
Director04 Aug 20212017₹1,292 Cr (FY 2025)Active
Partner25 Jun 20122011₹21.31 Cr (FY 2020)Active
Designated Partner25 Jun 20102010₹18.21 Cr (FY 2023)Active
Designated Partner25 Jun 20102010₹13.1 Lakh (FY 2023)Active
Pharma Platforms Private Limited U21001KA2026PTC227870
Individual Subscriber15 Sep 20262026Active
Karuna Group Llp ACR-1559
Designated Partner08 Sep 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Jul 20102010Active
Additional Director22 Dec 20232007₹81.13 Cr (FY 2025)Active
Patsys Consulting Private Limited U74140DL2006PTC146649
Director21 Feb 20062006₹33.44 Cr (FY 2022)Amalgamated
Alivira Animal Health Limited U74120MH2013PLC248708
Director27 Mar 20142013₹393 Cr (FY 2025)Active
Director11 Dec 20142007₹29.18 Cr (FY 2025)Active
Goose Technologies Private Limited U72200TG2004PTC042572
Director04 Aug 20072004₹15 Lakh (FY 2025)Active
Agila Specialties Private Limited U02429TG2004PTC093829
Director03 Mar 20042004Amalgamated
Fork Media Group Private Limited U74120MH2013PTC241023
Director31 Jul 20172013₹48.28 Cr (FY 2025)Active
Sequent Scientific Limited U24110MH2002PLC136868
Director16 Aug 20022002Amalgamated
Fraxis Life Sciences Limited U24117MH2007PLC210962
Director12 Jan 20072007Amalgamated
Arcolab (India) P.Ltd U24231KA1994PTC047003
Director28 Mar 19941994Amalgamated
Grandix Pharmaceuticals Limited U24231TN1996PLC035068
Director20 Jan 20071996Amalgamated
Skanray Healthcare Private Limited U85100KA2010PTC054613
Director29 Jul 20102010Amalgamated
Partner05 Mar 20222010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Arun Kumar Pillai

NameDINCompanyDesignation
Aditya Arun Kumar06999081Strides Pharma Science Limited , Pharma Platforms Private Limited and 1 moreDirector
Ameet Pratapsinh Hariani00087866Strides Pharma Science LimitedDirector
Badree KomandurStrides Pharma Science LimitedCeo
Badree Komandur07803242Strides Pharma Science LimitedManaging Director
Homi Rustam Khusrokhan00005085Strides Pharma Science LimitedDirector
Kausalya Santhanam06999168Strides Pharma Science Limited , Solara Active Pharma Sciences LimitedDirector
Manjula RamamurthyStrides Pharma Science LimitedCompany Secretary
Mukta Malik Arora07225715Strides Pharma Science LimitedDirector
Subir Chakraborty00130864Strides Pharma Science LimitedDirector
Venkata Seetharama Raju Pakalapati07500141Strides Pharma Science LimitedWhole-Time Director
Vikesh KumarStrides Pharma Science LimitedCfo
Allada TrishaOnesource Specialty Pharma LimitedCompany Secretary
Anurag BhaganiaOnesource Specialty Pharma LimitedCfo
Bharat Dhirajlal Shah00136969Onesource Specialty Pharma LimitedDirector
Claudio Dr Albrecht10109819Onesource Specialty Pharma LimitedDirector
Colin Bond Michael10982819Onesource Specialty Pharma LimitedDirector
Debarati Sen07521172Onesource Specialty Pharma LimitedDirector
Neeraj Sharma09402652Onesource Specialty Pharma LimitedManaging Director
Rashmi Harshadrai Barbhaiya10593871Onesource Specialty Pharma LimitedDirector
Vijay Paul Karwal10905781Onesource Specialty Pharma LimitedDirector
Manish Gupta06805265Solara Active Pharma Sciences LimitedDirector
Pooja Jaya KumarSolara Active Pharma Sciences LimitedCompany Secretary
Rajendra Kumar Srivastava07500741Solara Active Pharma Sciences LimitedDirector
Rajiv Vijay Nabar10383397Solara Active Pharma Sciences LimitedDirector
Ramakrishnan Rajagopal00161542Solara Active Pharma Sciences LimitedDirector

Directorship timeline

Open interactive timeline →
Onesource Specialty Pharma Limited
Sequent Scientific Limited
Fraxis Life Sciences Limited
Solara Active Pharma Sciences Limited
Premium access

Shareholding and investment profile for Arun Kumar Pillai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Kumar Pillai

Arun Kumar Pillai currently holds 9 directorships: Strides Pharma Science Limited (Director, since 05 Apr 2025, revenue ₹5,009 Cr (FY 2026)); Onesource Specialty Pharma Limited (Director, since 07 Apr 2021, revenue ₹1,437 Cr (FY 2026)); Solara Active Pharma Sciences Limited (Director, since 04 Aug 2021, revenue ₹1,292 Cr (FY 2025)); Pronomz Ventures Llp (Partner, since 25 Jun 2012, revenue ₹21.31 Cr (FY 2020)); Agnus Capital Llp (Designated Partner, since 25 Jun 2010, revenue ₹18.21 Cr (FY 2023)); and 4 more.

Arun Kumar Pillai was first appointed on 28 Mar 1994 as Director at Arcolab (India) P.Ltd. The most recent appointment on record is 15 Sep 2026 at Pharma Platforms Private Limited.

The 6 current companies of Arun Kumar Pillai that report revenue have a combined latest revenue of ₹7,778 Cr: Strides Pharma Science Limited ₹5,009 Cr (FY 2026); Onesource Specialty Pharma Limited ₹1,437 Cr (FY 2026); Solara Active Pharma Sciences Limited ₹1,292 Cr (FY 2025); Pronomz Ventures Llp ₹21.31 Cr (FY 2020); Agnus Capital Llp ₹18.21 Cr (FY 2023); and 1 more.

Arun Kumar Pillai held 28 earlier board appointments: Qualichem Remedies Llp (Designated Partner, 09 Jul 2010 to 06 Jun 2025); Quadgen Wireless Solutions Private Limited (Additional Director, 22 Dec 2023 to 28 Sep 2024); Patsys Consulting Private Limited (Director, 21 Feb 2006 to 29 Sep 2016); Alivira Animal Health Limited (Director, 27 Mar 2014 to 26 May 2015); Spire Technologies And Solutions Private Limited (Director, 11 Dec 2014 to 01 Jul 2020); and 23 more.

The current boards of Arun Kumar Pillai's companies include Aditya Arun Kumar (Strides Pharma Science Limited), Ameet Pratapsinh Hariani (Strides Pharma Science Limited), Badree Komandur (Strides Pharma Science Limited), Badree Komandur (Strides Pharma Science Limited), Homi Rustam Khusrokhan (Strides Pharma Science Limited), Kausalya Santhanam (Strides Pharma Science Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available